Spire Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Spire Wealth Management's LLY Position: Q3 2026 in Review
Spire Wealth Management increased its Eli Lilly (LLY) stake by 12% in Q3 2026, buying an estimated $4.02M and bringing the position to 31,342 shares worth $36.3M. The position accounts for 1.11% of the portfolio, ranked #10.
Spire Wealth Management first reported a position in LLY in Q1 2021 and has held it in 23 quarters since. The position peaked at $40.8M in Q1 2024. 2,281 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Spire Wealth Management held 31,342 shares of Eli Lilly worth $36.3M as of Q3 2026.
- Spire Wealth Management bought 3,404 Eli Lilly shares in Q3 2026, an estimated $4.02M.
- Eli Lilly made up 1.11% of Spire Wealth Management's portfolio in Q3 2026, its #10 holding.
- Spire Wealth Management first reported a position in Eli Lilly in Q1 2021 and has held it in 23 quarters since.
- Spire Wealth Management's Eli Lilly position peaked at $40.8M in Q1 2024.
- 2,281 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.